Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones Pharmaceutical TechnologyEurope contemplates unified drug prices to counter US pressure to spend more.Read full story pharminent August 27, 2026 (Last updated: September 1, 2026) Pharmaceutical Technology Europe contemplates unified drug prices to counter US pressure to spend more. Read full story Post navigation Previous: FDA Approves Revolution Medicines’ Rasonque, First RAS(ON) Inhibitor for Metastatic Pancreatic CancerNext: New data could widen use of AstraZeneca, Amgen immune disease drug Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
